experience was confined to the NHS, and conceded that NHS management itself leaves much to be desired. He, like the other two speakers, thought that 'the NHS Left' should stop being so defensive about the existence of the independent sector, and cited the Hon. Barbara Castle's attitude as Health Minister in the 1970s as having been one of the worst examples of counterproductive hostility in modern times. Only by abandoning such an approach, he said, could the NHS hope to make the best of the situation and turn its opportunities for using all available facilities to good acount.
During the remaining half hour of questions from the floor, the matters already raised were further discussed. Mr Wall mentioned provision for the elderly as a field where cooperation between private and public sectors made particularly good sense. Mr Randle endorsed this, and went on to remark that, contrary to what had been suggested earlier, private medicine could in his view provide emergency services, but only in such a context of joint planning. He also said that he did not much favour the kind of short-term contracting-out that Mr Wall had earlier described because he thought we ought to be aiming at a more comprehensive and ongoing sharing of resources. He differed from Mr Studd in thinking that the real problem was not the overall lack of money for health care but the way that the money was used. It was agreed that doctors have never been very prepared to evaluate results.
Mr Wall said that a problem that worried him particularly, as an administrator, was the inadequacy of nursing cover on many wards, especially at night. We should, he suggested, explore further the fact that the average nurse, after her 3 years training, only works 5 more years: could this poor return on investment be improved by, for example, the establishment of creches for staff children within hospitals? He also felt that the very low rates of pay currently received by hospital ancillary staff (domestics, etc.) was bad policy in any terms. At the other extreme, however, he thought that the NHS should abandon the notional goal of 'long-term planning', since who knew what other developments and changes would have occurred by the turn of the century?
A lady speaking from the floor appeared to consider 'commercial' a dirty word, and it was explained again by the panel of speakers that the NHS must, like all other bodies, think commercially in order to avoid wasting its money. Mr Randle remarked that, in any case, roughly half of the services on offer in the private sector are not structured for profit. In pursuance of the topic of sharing, it was suggested that private sector capital might be placed at the disposal of the NHS in return for the use of NHS facilities. Mr Studd speculated on the alternative possibility of a complete separation between free and fee-paying systems, but it was felt that it was a little late in the evening to explore this.
In conclusion, Mr Randle remarked that it is always difficult to criticize a managerial set-up constructively, since we are all victims of our own circumstances: in this case the circumstances consisted of the hard-to-reconcile demands of our political masters on the one hand and of the consumers -the patients -on the other.
The present rapporteur felt that this interesting evening would have gained further from some specific discussion of how health care is delivered in other European countries who have managed to avoid the evolution of two separate systems, but, although each of the speakers seemed to be aware of this as a background fact, none explored it. Dr Martin Brueton (Westminster Children's Hospital, London) started the morning session and discussed the role of the lymphomyeloid infiltrates in health and disease. 'The gut is an exterior exposure to antigen in the interior milieu (milieu exterieur in the milieu interieur).' The general function of mucosal immunity includes: (1) immune exclusion, i.e. surface protection mediated by antibodies (IgA) in cooperation with innate non-specific factors such as mucin from goblet cells, and lysozyme (which forms an 'antiseptic paint' over gut mucosa); (2) immune elimination, i.e. mechanisms involved in the removal of foreign material which has penetrated the mucosal barrier -antibodies acting in combination with T-cells and K ('killer') cells; (3) immune regulation, which determines the balance between immunity (protective), tolerance and hypersensitivity'. The gut-associated lymphoid tissue (GALT) consists of discrete lymphoid aggregates (Peyer's patches) and lymphoid cells dispersed throughout the lamina propria and epithelial layer. The 'first signals' to the lymphoid cells (both Band T-cells) probably depend on antigen uptake by the epithelium covering the domes of solitary follicles and Peyer's patches in the small intestine.
There are specialized microfold 'M' cells ('membrane') in the dome epithelium of Peyer's patches designed for sampling and inward transport of luminal antigens. These mature M cells can be identified in rabbits, rats, mice and humans. In addition to epithelial M cells, normal human Peyer's patches contain numerous HLA-DR positive dendritic cells and macrophages which probably act as antigenpresenting cells. Most soluble antigens have to be presented to helper T (Th) cells along with HLA-DR (or class II MHC determinants) to elicit B-cell responses. The activated B-cells migrate through mesenteric lymph nodes and peripheral blood, and are finally returned to the lamina propria where they develop into Ig-producing plasma cells. Historically, the recognition of the role of IgA led to an emphasis on the identification of plasma cells in the lamina propria. In fact, T-cells predominate and B-cells outnumber plasma cells. IgA-secreting plasma cells predominate (over IgG, IgM plasma cells) and are of equal proportions of the IgA I and IgA 2 subclass. The production of J chain is prominent, leading to formation of IgA dimers which are then secreted into the intestinal lumen as secretory IgA after combining with secretory component (SC) which is produced by the columnar epithelial cells of the crypts of Lieberkuhn. SC acts as a receptor in the external transport of dimeric IgA. Pentameric IgM is also secreted from the lamina propria by combining with SC, but to a lesser extent.
In the lamina propria (LP) the ratio ofTh lymphocytes expressing the OK T 4 marker to T suppressor/ cytotoxic lymphocytes (OK T s) is 3:2. Null cells, NK and K cells and mast cells are also present. LP OK T 4 helper cells are not restricted to the IgA class but enhance IgG and IgM synthesis as well.
Intraepithelial lymphocytes (IEL) in general express cytotoxic/suppressor cell markers in man. In rodents, granular cells within this population resemble large granular lymphocytes which display NK cell activity in vitro. IEL can also mediate antibody-dependent cell-mediated cytotoxicity with IgA against enteric microorganisms, and are able to induce Class II MHC or la-like expression in surface and crypt enterocyte. This is exemplified by the presence of activated or blast transformed lymphocytes in coeliac disease and tropical sprue.
Professor Peter Isaacson (University College Hospital, London) discussed B-cell lymphoma in the context of the microanatomy of normal human gutassociated lymphoid tissue (GALT). Using a panel of monoclonal antibodies, he illustrated his talk with immunohistochemical sections to show that centroeyre-like cells (which are phenotypically distinct from centrocytes and centroblasts of a follicle in Peyer's patches) are present as a broad zone ofB-cells which surround the mantle zone. These cells are found over the dome regions of the lymphoid follicles". Neoplastic centrocyte-like cells with the phenotypic features described have been observed only in lymphomas of mucosa-associated lymphoid tissue and not in tumours of peripheral lymph nodes. These cells are the malignant equivalent of the centrocytelike cells which surround the lymphoid follicles in normal human GALT; there is some suggestion that they correspond to memory B-cells in the ontogeny of B-cell maturation.
The homing proclivities of GALT B-cells (migrating via the mesenteric nodes, the thoracic duct lymph and the blood to reach the lamina propria) may explain why gut lymphomas remain localized for a long time and also explain why they respond well to local therapy.
While factors which influence the selective return of T or B-cells to the intestinal mucosa still need to be explained, Professor D M V Parrot from Glasgow reminded the audience of the three important concepts on cell traffic in the small bowel: (1) the significance of specialized high endothelial venules which are the route of entry of lymphocytes into Peyer's patches (like peripheral lymph nodes);
(2) homing of lymphocytes as first described by Gowans and Knight in 1964;
(3) the concept of organ or tissue recognition by lymphocytes. Over the last 20 years, the concept of 'homing' and of endothelial recognition sites has aroused such enthusiasm among investigators that other straightforward physiological factors have been relatively neglected. She redressed the balance by drawing attention to the importance of blood flow to the distribution and localization of lymphocytes. Also the role of local tissue factors that affect cell retention can playa part in controlling lymphocyte accumulation or 'selectivity', as lymphocytes leave as well as enter the mucosa.'. For example, after primary infection with a parasitic worm Trichinella spiralis, lymphoblasts may remain longer within the mucosa of intestine rather than being more avidly taken up.
In a critical presentation, Dr T MacDonald (St Bartholomew's Hospital, London) discussed the previous data on functional immunological studies of mucosal lymphocytes in animals and man. At St Bartholomew's Hospital, Dr MacDonald has been able to study intestinal lymphocytes in children with chronic inflammatory bowel disease during routine colonoscopy by selectively biopsying Peyer's patches as well as areas of ileum or colon which have no follicles. Using a panel of monoclonal markers, his studies have shown increased populations of T-lymphocytes (although there is no change in the ratio of helper to suppressor cells as defined by phenotype) in Peyer's patches in Crohn's disease. Functional studies have shown that PHA-induced proliferation ofPeyer's patch lymphocytes is greater than the response of lamina propria lymphocytes. In addition, Peyer's patch cells from patients with Crohn's disease responded less well to PHA than disease controls. The biological significance ofthese responses are unknown, but the increased production ofimmunoglobulin in the mucosa and the presence of activated T-cells suggest an immunological effector role in the pathogenesis of chronic inflammation. The increased response to gut antigens absorbed through inflamed mucosa may be facilitated by the expression of Class II antigens on the villus enterocytes of inflamed mucosa. However, this Class II expression disappears when the patient is in remission.
In discussing epithelial lymphocytes in coeliac disease, Dr Michael N Marsh (University of Manchester) first drew attention to the errors inherent in counting lymphocyte profiles in 2dimensional microscope sections, and then making the assumption that the data reflect actual numbers of lymphocytes within the original (3-dimensional) mucosal specimen".
Reviewing his studies on epithelial lymphocytes in coeliac patients, Dr Marsh showed that there was extensive blast transformation of epitheliallymphocytes and a high proliferative rate, both of which were shown to be gluten-induced. In contrast to surface epithelium, where the absolute number of lymphocytes was reduced because of increased cell turnover, coeliac crypt epithelium was shown to contain a considerable expanded population of large blast-transformed lymphocytes. Since the crypts were engaged in an enormous compensatory response to losses of surface enterocytes, Dr Marsh argued that it was difficult to imagine how the increased population of lymphocytes could have any damaging effect on their capacity to hypertrophy and differentiate.
In patients with treated coeliac disease, as a result of gluten restriction, Dr Marsh showed that it was possible to obtain a time-dependent, dose-related increase in epithelial lymphocytes following graded oral challenges with Frazer's fraction 3 (doses: 100, 500, 1000 and 1500mg respectively). Here again the influx of lymphocytes, both into crypts as well as villous epithelium, caused no deterioration in mucosal structure. Furthermore, and in contrast to untreated coeliacs, the post-challenge lymphocyte population comprised small, non-mitotic cells.
In discussing the first-and second-degree relatives of coeliac patients in Manchester and Liverpool, Dr Marsh finally showed that 38% of patients had increased populations of villous lymphocytes. Despite these increased epithelial lymphocyte populations, mucosal morphology as determined by computerized image-analysis techniques was normal, as was epithelial permeability, judged by the sICr-EDTA test.
The conclusions that emerged from these data were that epithelial lymphocytes per se could not reasonably be regarded as the primary agents associated with mucosal destruction.
Dr Stephan Strobel took the view that mucosal damage, as seen in coeliac disease, cannot be solely attributed to mast cell mediated response. Earlier studies on the role of the intestinal mucosal mast cell in coeliac disease were performed retrospectively without appreciation of the critical importance for the correct fixation and staining procedures of the biopsies. These studies had also failed to include disease controls with a flat mucosa and had not demonstrated a decrease in mucosal mast cell numbers after a gluten free diet.
On balance, the evidence suggests that mucosal mast cells are most likely secondarily recruited to the site of tissue injury and are not specific for the underlying disease process. However they could act as an amplifying mechanism within the framework of adverse immune responses to gluten in the small bowel enteropathy.
Dr Ian Sanderson (St Bartholomew's Hospital, London) showed that mucosal mast cells also do not appear to play an important role in the pathogenesis of Crohn's disease in childhood. The density of mast cells in the mucosa and their histamine content are actually reduced in active disease. There are no differences in histamine release following challenge of biopsies from Crohn'spatients and disease controls with anti-IgE antibody.
The immunology of gut anaphylaxis and worm expulsion was discussed by Dr R Mogbel (Brompton Hospital, London). He studied the involvement of leukotrienes in protective responses against helminth in two gut anaphylaxis models. First, using Nippostrongylus brasiliensis-infected rats, significantly elevated concentrations of LTB 4 and LTC 4 were found in the gut tissue and in the lumen of the bowel of the immune animals after challenge. Plasma LTB 4 and LTC 4 levels were also elevated together with evidence of mucosal mast cell activation as measured by increased concentrations of the specific enzyme rat mast cell protease II (RMCP II)'.
In the second model, he utilized the phenomenon of rapid expulsion of the nematode, lrichinella spiro lis, from immune rats to demonstrate immediate hypersensitivity, and again showed that biologicallyactive mediators such as leukotrienes were released during protective responses against helminths in immune animals. Mediators may therefore contribute to the creation and/or exacerbation of a state of hyper-responsiveness in the gut, rendering it unfavourable for the parasites and resulting in their elimination from the host.
Professor Allan Walker (Massachusetts General Hospital, Boston, USA) rounded off the meeting by talking about antigen entry from the gut lumen. He reminded the audience of the importance of a mucus coat in the microvillous border, which is an important physical barrier to antigen penetration and expulsion. It also contains receptor analogues to bacteria,thereby preventing their attachment. The formation ofIgA-immune complexes on the surface of the small intestine seems to enhance the release of mucus. In intestinal anaphylaxis and IgE-mediated disease, histamine causes mucus release from goblet cells. Factors released from mast cells may also enhance peristalsis (an important nonspecific defence mechanism which causes expulsion of bacteria, parasite and antigen from the mucosal surface). It has also been shown that parasite infestation, antigen stimulus and release of leukotrienes and mast cell mediators may also have an effect on maturation of villous enterocytes as well as worm expulsion.
Conditions which may predispose to an alteration of the mucosal barrier include prematurity, malnutrition, immune deficiency, transient disruption of mucosa due to viral gastroenteritis, alteration in digestion, or dysfunction of the liver. He concentrated on the premature newborn and developmental abnormalities encountered, e.g. transient IgA deficiency, alteration in the surface of the intestine, disruption of the intraluminal digestion, enhanced bacterial adherence, and increased macromolecular transport".
The preterm infant has an abnormal mucosal immune response -enhancement of systemic immune responsiveness (lgG and IgE plasma cell production). This seems to relate to an increased uptake of antigen and appears to affect the balance between T-helper/ suppressor responses. When full-term normal neonates were fed infant formula, or breastfed for three months and then fed infant formula, the latter group had a lower systemic immune response than the former. This suggested that not only were antigens taken across but that the response was enhanced.
The attachment of bacteria to the intestinal surface depends on the glycoprotein composition (specifically the carbohydrate side chain of the glycoprotein surface). There are known adherent factors (or receptors) on intestinal surface for a variety of bacteria or toxins, e.g. E. coli interacts with mannose, Vibrio cholera interacts with fucose. Cholera toxin binds to N-acetylgalactosamine and shigella toxin binds to N-acetylglucosamine. Using lectin binding to identify available glycoconjugates, the incorporation of sugars into glycoproteins and by examining glycosyl transferase such as sialo transferase and fucosyl transferase, glycosylation can be studied in stages as the intestine develops. This is clinically relevant, because the absence ofN-acetylgalactosamine ill' the microvillous surface in neonates may explain the presence of clostridia in the gut and the absence of toxigenic disease. The differences in glycoconjugates on the intestinal surface may be the factor contributing to the increased attachment of bacteria and increased incidence of intestinal allergy in the young infant. Binding is a necessary prerequisite in the uptake of antigens on the intestinal surface. More recently, Bresson has demonstrated that there is considerably greater binding of cholera toxin to the newborn membrane than to the adult intestinal membrane?
Professor Walker concluded by discussing mucosal barrier components in breast milk as an interventive measure. There are passive protective factors, e.g. IgA antibodies, glycoprotein receptor inhibitors for bacteria and toxins, proteolytic enzyme and mucosal growth factors. Also recent work has been done in necrotizing enterocolitis in experimental animals showing that cortisol results in increased lectin binding and prevents bacterial attachment. There was a decreased incidence of necrotizing enterocolitis in infants in a clinical trial where mothers at risk of delivering premature infants were given cortisol. Thyroxine could also be a growth factor in the neonatal rodent by causing an early maturation of the capacity of the gut to bind maternal IgG with a striking decrease in antigen penetration. In the same way epidermal growth factor in breast milk could well be important in protecting the mucosal surface of the intestine of the neonate.
There is an enormous amount of new knowledge in gastrointestinal immunology waiting to be harnessed in clinical medicine. Sadly, this short symposium was insufficient to discuss these implications. The role of the liver was not covered at this meeting. Nevertheless, the meeting was 'antigenic' and provoking to the aspiring clinician who should have
Letters to the Editor
Preference is given to letters commenting on contributions published recently in the JRSM. They should not exceed 400 words and should be typed double-spaced.
Tenosynovitis
Sir, The term 'tenosynovitis' is most unsatisfactory.
Both Mr Helal (February JRSM, p 68) and Mr Campbell Semple' have written of its devaluation by loose usage. Mr Semple is so concerned with the overriding influences of compensation provisions and the legal process that he even doubts the significance of tenderness in structures if these factors are operating".
In Australia there has been an epidemic of upper limb pain, and equally unsatisfactory collective Journal of the RoyalSociety of Medicine Volume80 October 1987 659 been nudged from complacency into keeping up with colleagues in immunology.
